{
    "title": "US FDA declines to approve Ascendis' hormone disorder therapy",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12033309/U-S-FDA-declines-approve-Ascendis-hormone-disorder-therapy.html",
    "date": "2023-05-01",
    "keywords": [
        "therapy",
        "companys",
        "approval",
        "drug",
        "hormone",
        "fda",
        "transcon",
        "pth",
        "stock",
        "year",
        "monday",
        "food",
        "administration",
        "adult",
        "disorder",
        "hypoparathyroidism",
        "control",
        "device",
        "combination",
        "premarket",
        "trade",
        "agency",
        "response",
        "letter",
        "ascendis",
        "meeting",
        "path",
        "forward",
        "value",
        "month",
        "application",
        "note",
        "cowen",
        "analyst",
        "yaron",
        "lack",
        "clarity",
        "decision",
        "conference",
        "thursday",
        "preclinical",
        "study",
        "delay",
        "end",
        "werber",
        "case",
        "uptake",
        "deficient",
        "parathyroid",
        "feature",
        "disease",
        "mariam",
        "sunny",
        "bengaluru",
        "editing",
        "anil",
        "dsilva",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}